Table 5 Performance metrics of the validation phase.

From: Development and clinical validation of Swaasa AI platform for screening and prioritization of pulmonary TB

Statistic

Value

95% CI

Sensitivity

90.36%

81.89–95.75%

Specificity

84.67%

77.53–90.25%

Positive likelihood ratio

5.90

3.95–8.79

Negative likelihood ratio

0.11

0.06–0.22

Disease prevalence

37.73%

31.30–44.49%

Positive predicate value

78.12%

70.54–84.19%

Negative predicate value

93.55%

88.20–96.57%

Accuracy

86.82%

81.62–90.99%

Back to article page